JACC: Cardiovascular Interventions
Clinical Research
Long-Term Outcomes in High-Risk Symptomatic Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation
Deborah H. Kwon, Samir R. Kapadia, E. Murat Tuzcu, Carmel M. Halley, Eiran Z. Gorodeski, Ronan J. Curtin, Maran Thamilarasan, Nicholas G. Smedira, Bruce W. Lytle, Harry M. Lever and Milind Y. Desai
Table 2
Table 2
Description of Alcohol Septal Ablation Patients Who Died During Follow-Up
Deceased Patient | Age at Procedure (yrs) | Reason for Referral to Alcohol Septal Ablation | Age at Death (yrs) | Cause of Death |
---|---|---|---|---|
1 | 82 | Old age | 85 | Respiratory failure |
2 | 77 | Old age | 84 | Unknown |
3 | 83 | Old age | 84 | Unknown |
4 | 63 | History of multiple valve surgeries | 70 | Liver failure |
5 | 82 | Old age | 88 | Unknown |
6 | 83 | Old age | 84 | Cardiac arrest |
7 | 78 | Old age | 81 | Unknown |
8 | 69 | History of recurrent venous thrombosis | 74 | Unknown |
9 | 60 | Severe lung disease | 62 | Unknown |
10 | 65 | Significant psychiatric problems | 71 | Pneumonia |
11 | 71 | Old age plus active cholecystitis | 78 | Unknown |
12 | 66 | Cirrhosis of liver | 69 | Cirrhosis of liver |
13 | 46 | Severe renal failure | 46 | Renal Failure |
Advertisement